Cytosorbents Corporation Share Price
NASDAQ: CTSO | Micro CapCytosorbents Corporation Stock Performance
Cytosorbents Corporation Share Price Chart
Cytosorbents Corporation Quarterly Profit & Loss
All figures in USD
Cytosorbents Corporation Annual Profit & Loss
All figures in USD
About Cytosorbents Corporation
CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.
Cytosorbents Corporation Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $4.25 | $3.80 | -7.54% |
Sep 2026 | $0.35 | $4.11 | +1,094.77% |
Aug 2026 | $0.37 | $0.34 | -13.78% |
Jul 2026 | $0.39 | $0.40 | +6.40% |
Jun 2026 | $0.47 | $0.38 | -23.47% |
May 2026 | $0.60 | $0.49 | -23.44% |
Apr 2026 | $0.56 | $0.64 | +12.28% |
Mar 2026 | $0.74 | $0.57 | -22.02% |
Feb 2026 | $0.67 | $0.73 | +15.66% |
Jan 2026 | $0.66 | $0.63 | +0.80% |
Dec 2025 | $0.82 | $0.63 | -24.09% |
Nov 2025 | $0.79 | $0.83 | +3.77% |